コンテンツへスキップ
Merck
  • Intermediate and low abundant protein analysis of vitamin D deficient obese and non-obese subjects by MALDI-profiling.

Intermediate and low abundant protein analysis of vitamin D deficient obese and non-obese subjects by MALDI-profiling.

Scientific reports (2017-10-05)
Nasser M Al-Daghri, Enrica Torretta, Daniele Capitanio, Chiara Fania, Franca Rosa Guerini, Shaun B Sabico, Mario Clerici, Cecilia Gelfi
要旨

Obesity is a pathological condition caused by genetic and environmental factors, including vitamin D deficiency, which increases the risk of developing cardiovascular disorders and diabetes. This case-control study was designed to verify whether serum profiles could be identified differentiating obese and non-obese Saudis characterized by vitamin D deficiency and pathological levels of triglycerides, high-density lipoprotein cholesterol and high total cholesterol levels. The serum protein profiles of 64 vitamin D deficient (serum 25(OH)D < 50nmol/L) individuals with metabolic syndrome and with (n = 31; BMI ≥ 30) or without (n = 33; BMI < 30) obesity were analyzed by a quantitative label-free mass spectrometry approach (MALDI-profiling), combined with different serum immunodepletion strategies (Human7 and Human14 immuno-chromatographies), to analyze the intermediate- and low-abundant protein components. The analysis of intermediate-abundant proteins (Human7) in obese vs. non-obese subjects identified 14 changed peaks (p < 0.05) in the m/z range 1500-35000. Furthermore, the Human14 depletion provided new profiles related to obesity (121 changed peaks). Among changed peaks, 11 were identified in the m/z range 1500-4000 Da by high-resolution tandem mass spectrometry, belonging to apolipoprotein CIII, apolipoprotein B100, alpha-1-antichymotrypsin and complement C3. Data herein show that distinct protein profiles identify specific peptides belonging to lipid metabolism and inflammation processes that are associated with obesity and vitamin D deficiency.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ジヒドロキシアセトンリン酸 二リチウム塩, ≥93% dry basis (enzymatic)